...
首页> 外文期刊>Pancreas >Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival
【24h】

Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival

机译:髓质胰腺癌由于躯体杆突变引起的一种独特的胰腺癌,具有显着的长期存活

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Medullary pancreatic carcinoma (MPC) is a rare histological variant of pancreatic ductal adenocarcinoma (PDAC). Because of its rarity, data on the molecular background of MPC are limited. Previous studies have shown that a subset of MPCs is microsatellite instable due to mismatch repair deficiency. Here, we present a unique case of a female patient in her 60s who is a long-term survivor after surgery for pancreatic cancer. The patient had a microsatellite stable MPC with a somatic mutation of the polymerase epsilon gene (POLE). Both microsatellite instable andPOLE-mutated cancers are usually associated with high tumor mutational burden and antigen load, resulting in a prominent antitumor immune response and overall better survival. The current case illustrates that, in addition to mismatch repair deficiency, MPC can develop because of a somaticPOLEmutation, resulting in a tumor with a high tumor mutational burden and leading to a better prognosis compared with conventional PDAC. This new finding may have important implications in the management of patients with MPC and calls for further studies on the role ofPOLEin PDAC.
机译:髓质胰腺癌(MPC)是胰腺导管腺癌(PDAC)的罕见组织学变体。由于其稀有性,MPC的分子背景上的数据有限。以前的研究表明,由于不匹配的修复缺陷,MPCS的子集是毫无稳定的。在这里,我们在她的60年代患有一个女性患者的独特案例是胰腺癌手术后的长期幸存者。患者具有微卫星稳定的MPC,具有聚合酶ε基因(极)的体细胞突变。微卫星稳定的andpole-突变的癌症通常与高肿瘤突变负担和抗原载荷相关,导致初始抗肿瘤免疫应答和整体更好的存活率。目前的情况说明,除了不匹配的修复缺陷之外,MPC可以由于索细漏洞而发展,导致肿瘤突变负担的肿瘤,导致与常规PDAC相比更好的预后。这种新发现可能对MPC患者的管理有重要意义,并要求进一步研究Polein PDAC的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号